Advanced search
Publication Cover
Regenerative Medicine Volume 9, 2014 - Issue 5
Submit an article Journal homepage
200
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Induced Pluripotent Stem Cells have Similar Immunogenic and More Potent Immunomodulatory Properties Compared with Bone Marrow-Derived Stromal Cells in Vitro

Lauren V Schnabel1 Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC27607, USAView further author information
,
Christian M Abratte2 Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY14853, USAView further author information
,
John C Schimenti2 Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY14853, USAView further author information
,
M Julia Bevilaqua Felippe3 Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY14853, USAView further author information
,
Jennifer M Cassano3 Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY14853, USAView further author information
,
Teresa L Southard2 Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY14853, USAView further author information
,
Jessica A Cross3 Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY14853, USAView further author information
&
Lisa A Fortier3 Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY14853, USACorrespondence[email protected]
View further author information
 show all
Pages 621-635 | Published online: 28 Apr 2014

References

  • Takahashi K , YamanakaS. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell126(4) , 663–676 (2006).
  • Takahashi K , TanabeK, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell131(5) , 861–872 (2007).
  • Takahashi K , NaritaM, Yokura M et al. Human induced pluripotent stem cells on autologous feeders. PLoS ONE4(12) , e8067 (2009).
  • Sun N , LongakerMT, WuJC. Human iPS cell-based therapy: considerations before clinical applications. Cell Cycle9(5) , 880–885 (2010).
  • Hussein SM , BatadaNN, Vuoristo S et al. Copy number variation and selection during reprogramming to pluripotency. Nature471(7336) , 58–62 (2011).
  • Tang C , DrukkerM. Potential barriers to therapeutics utilizing pluripotent cell derivatives: intrinsic immunogenicity of in vitro maintained and matured populations. Semin. Immunopathol.33(6) , 563–572 (2011).
  • Okita K , NagataN, YamanakaS. Immunogenicity of induced pluripotent stem cells. Circ. Res.109(7) , 720–721 (2011).
  • Drukker M . Immunological considerations for cell therapy using human embryonic stem cell derivatives. StemBook10.3824/stembook.1.14.1 (2008) (Epub ahead of print).
  • de Almeida PE , RansohoffJD, Nahid A et al. Immunogenicity of pluripotent stem cells and their derivatives. Circ. Res.112(3) , 549–561 (2013).
  • Jiang Z , HanY, CaoX. Induced pluripotent stem cell (iPSCs) and their application in immunotherapy. Cell. Mol. Immunol.11(1) , 17–24 (2014).
  • Schnabel LV , AbratteCM, Schimenti JC et al. Genetic background affects induced pluripotent stem cell generation. Stem Cell. Res. Ther.3(4) , 30 (2012).
  • Fairchild PJ . The challenge of immunogenicity in the quest for induced pluripotency. Nat. Rev. Immunol.10(12) , 868–875 (2010).
  • Waterman RS , TomchuckSL, Henkle SL et al. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype. PLoS ONE5(4) , e10088 (2010).
  • Bunnell BA , BetancourtAM, SullivanDE. New concepts on the immune modulation mediated by mesenchymal stem cells. Stem Cell. Res. Ther.1(5) , 34 (2010).
  • Prockop DJ . Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms. Mol. Ther.17(6) , 939–946 (2009).
  • Aggarwal S , PittengerMF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood105(4) , 1815–1822 (2005).
  • Stagg J . Immune regulation by mesenchymal stem cells: two sides to the coin. Tissue Antigens69(1) , 1–9 (2007).
  • Stagg J , GalipeauJ. Immune plasticity of bone marrow-derived mesenchymal stromal cells. Handb. Exp. Pharmacol. (180) , 45–66 (2007).
  • Griffin MD , RitterT, MahonBP. Immunological aspects of allogeneic mesenchymal stem cell therapies. Hum. Gene Ther.21(12) , 1641–1655 (2010).
  • Peister A , MelladJA, Larson BL et al. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood103(5) , 1662–1668 (2004).
  • Baxter MA , WynnRF, Jowitt SN et al. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells.22(5) , 675–682 (2004).
  • Majors AK , BoehmCA, Nitto H et al. Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J. Orthop. Res.15(4) , 546–557 (1997).
  • Nasef A , MathieuN, Chapel A et al. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation84(2) , 231–237 (2007).
  • Nasef A , MazurierC, Bouchet S et al. Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression. Cell. Immunol.253(1–2) , 16–22 (2008).
  • Nasef A , ZhangYZ, Mazurier C et al. Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation. Int. J. Lab. Hematol.31(1) , 9–19 (2009).
  • Puissant B , BarreauC, Bourin P et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br. J. Haematol.129(1) , 118–129 (2005).
  • Di Nicola M , Carlo-StellaC, Magni M et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood99(10) , 3838–3843 (2002).
  • Jiang XX , ZhangY, Liu B et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood105(10) , 4120–4126 (2005).
  • Plumas J , ChaperotL, Richard MJ et al. Mesenchymal stem cells induce apoptosis of activated T cells. Leukemia.19(9) , 1597–1604 (2005).
  • Djouad F , PlenceP, Bony C et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood102(10) , 3837–3844 (2003).
  • Bartholomew A , SturgeonC, Siatskas M et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol.30(1) , 42–48 (2002).
  • Meisel R , ZibertA, Laryea M et al. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood103(12) , 4619–4621 (2004).
  • Le Blanc K , RasmussonI, Sundberg B et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet363(9419) , 1439–1441 (2004).
  • Eliopoulos N , StaggJ, Lejeune L et al. Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood106(13) , 4057–4065 (2005).
  • Potian JA , AvivH, Ponzio NM et al. Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J. Immunol.171(7) , 3426–3434 (2003).
  • Zangi L , MargalitR, Reich-Zeliger S et al. Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells. Stem Cells27(11) , 2865–2874 (2009).
  • Griffin MD , RyanAE, Alagesan S et al. Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far? Immunol. Cell Biol.91(1) , 40–51 (2013).
  • Nauta AJ , WesterhuisG, Kruisselbrink AB et al. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood108(6) , 2114–2120 (2006).
  • Badillo AT , BeggsKJ, Javazon EH et al. Murine bone marrow stromal progenitor cells elicit an in vivo cellular and humoral alloimmune response. Biol. Blood Marrow Transplant.13(4) , 412–422 (2007).
  • Jones EA , KinseySE, English A et al. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum.46(12) , 3349–3360 (2002).
  • Schnabel LV , PezzaniteLM, Antczak DF et al. Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro. Stem Cell. Res. Ther.5(1) , 13 (2014).
  • Chan WK , LauAS, Li JC et al. MHC expression kinetics and immunogenicity of mesenchymal stromal cells after short-term IFN-gamma challenge. Exp. Hematol.36(11) , 1545–1555 (2008).
  • Romieu-Mourez R , FrancoisM, Boivin MN et al. Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density. J. Immunol.179(3) , 1549–1558 (2007).
  • Zhao T , ZhangZN, RongZ, XuY. Immunogenicity of induced pluripotent stem cells. Nature474 , 212–216 (2011).
  • Guha P , MorganJW, Mostoslavsky G et al. Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell12(4) , 407–412 (2013).
  • Araki R , UdaM, Hoki Y et al. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature494(7435) , 100–104 (2013).
  • Chen HF , YuCY, Chen MJ et al. Characteristic expression of major histocompatibility complex and immune privilege genes in human pluripotent stem cells and the derivatives. Cell Transplant. doi:10.3727/096368913X674639 (2013) (Epub ahead of print).
  • Suarez-Alvarez B , RodriguezRM, Calvanese V et al. Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells. PLoS ONE5(4) , e10192 (2010).
  • Pearl JI , KeanLS, Davis MM et al. Pluripotent stem cells: immune to the immune system? Sci. Transl. Med.4(164) , 164ps25 (2012).
  • Kadereit S , TrounsonA. In vitro immunogenicity of undifferentiated pluripotent stem cells (PSC) and derived lineages. Semin. Immunopathol.33(6) , 551–562 (2011).
  • Bonde S , ZavazavaN. Immunogenicity and engraftment of mouse embryonic stem cells in allogeneic recipients. Stem Cells24(10) , 2192–2201 (2006).
  • Kaneko S , YamanakaS. To be immunogenic, or not to be: that‘s the iPSC question. Cell Stem Cell12(4) , 385–386 (2013).
  • Pearl JI , LeeAS, Leveson-Gower DB et al. Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells. Cell Stem Cell8(3) , 309–317 (2011).
  • Yachimovich-Cohen N , Even-RamS, ShufaroY et al. Human embryonic stem cells suppress T cell responses via arginase I-dependent mechanism. J. Immunol.184(3) , 1300–1308 (2010).
  • Mohib K , AllanD, WangL. Human embryonic stem cell-extracts inhibit the differentiation and function of monocyte-derived dendritic cells. Stem Cell.Rev.6(4) , 611–621 (2010).
  • Mohib K , AlKhameesB, Zein HS et al. Embryonic stem cell-derived factors inhibit T effector activation and induce T regulatory cells by suppressing PKC-theta activation. PLoS ONE7(3) , e32420 (2012).
  • Nagy K , SungHK, Zhang P et al. Induced pluripotent stem cell lines derived from equine fibroblasts. Stem Cell. Rev.7(3) , 693–702 (2011).
  • Kolf CM , ChoE, TuanRS. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res. Ther.9(1) , 204 (2007).
  • Meirelles Lda S , NardiNB. Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br. J. Haematol.123(4) , 702–711 (2003).
  • Baddoo M , HillK, Wilkinson R et al. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J. Cell. Biochem.89(6) , 1235–1249 (2003).
  • Cieri N , CamisaB, Cocchiarella F et al. IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors. Blood121(4) , 573–584 (2013).
  • Lu SY , LiuKY, Liu DH et al. High frequencies of CD62L(+) naive regulatory T cells in allografts are associated with a low risk of acute graft-versus-host disease following unmanipulated allogeneic haematopoietic stem cell transplantation. Clin. Exp. Immunol.165(2) , 264–277 (2011).
  • Chang YJ , ZhaoXY, Huo MR et al. Expression profiles of adhesion molecules on naive T cells in bone marrow grafts of healthy donors treated with granulocyte colony-stimulating factor. Transpl. Immunol.21(4) , 228–233 (2009).
  • Chang YJ , ZhaoXY, Huo MR et al. Expression of CD62L on donor CD4(+) T cells in allografts: correlation with graft-versus-host disease after unmanipulated allogeneic blood and marrow transplantation. J. Clin. Immunol.29(5) , 696–704 (2009).
  • Kruisbeek AM . Isolation of mouse mononuclear cells. Curr. Protoc. Immunol.39 , 3.1.1–3.1.5 (2001).
  • Kruisbeek AM , ShevachE, ThorntonAM. Proliferative assays for T cell function. Curr. Protoc. Immunol.60 , 3.12.1–3.12.20 (2004).
  • Muul LM , HeineG, Silvin C et al. Measurement of proliferative responses of cultured lymphocytes. Curr. Protoc. Immunol. Chapter 7, Unit 7.10 (2011).
  • Aladjem MI , SpikeBT, Rodewald LW et al. ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr. Biol.8(3) , 145–155 (1998).
  • You Y , BrowningVL, SchimentiJC. Generation of radiation-induced deletion complexes in the mouse genome using embryonic stem cells. Methods13(4) , 409–421 (1997).
  • You Y , BergstromR, Klemm M et al. Chromosomal deletion complexes in mice by radiation of embryonic stem cells. Nat. Genet.15(3) , 285–288 (1997).
  • Pellegata NS , AntonionoRJ, Redpath JL et al. DNA damage and p53-mediated cell cycle arrest: a reevaluation. Proc. Natl Acad. Sci. USA93(26) , 15209–15214 (1996).
  • Xu J , WangF, Tang Z et al. Role of leukaemia inhibitory factor in the induction of pluripotent stem cells in mice. Cell Biol. Int.34(8) , 791–797 (2010).
  • Koch CA , GeraldesP, PlattJL. Immunosuppression by embryonic stem cells. Stem Cells26(1) , 89–98 (2008).
  • DelaRosa O , LombardoE. Modulation of adult mesenchymal stem cells activity by Toll-like receptors: implications on therapeutic potential. Mediators Inflamm.2010 , 865601 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.